Nathan D. Jorgensen
Chief Financial Officer · Voyager Therapeutics, Inc.
- 2024
- Feb 26, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nathan D. Jorgensen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alfred Sandrock - $184K in VYGR purchases and sales in the last 12 months
- Robin Swartz - $55K in VYGR purchases and sales in the last 12 months
- Todd Alfred Carter - $41K in VYGR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nathan D. Jorgensen?
Nathan D. Jorgensen is a corporate insider, tracked as Chief Financial Officer of Voyager Therapeutics, Inc. (VYGR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Nathan D. Jorgensen last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 4 filings going back to 2024.
Has Nathan D. Jorgensen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($54K) across all tracked filings.
